Summary
Updated Aug 31, 2026
Richard T. Kenney is Chief Medical Officer of Sonnet BioTherapeutics Holdings, Inc. (SONN). 4 SEC Form 4 filings on record going back to 2024, most recently on 4 December 2025.
Recent Transactions
8Every recent SEC Form 4 transaction Richard T. Kenney has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Richard T. Kenney go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Richard T. Kenney's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Gary S. Guthart - $48.79M of ISRG open-market activity in the last 12 months
- Robert B. Ford - $48.22M of ABT open-market activity in the last 12 months
- Daniel Patrick O'Day - $47.86M of GILD open-market activity in the last 12 months
- Roger Adsett - $47.51M of INSM open-market activity in the last 12 months
- Bihua Chen - $46.87M of MLTX open-market activity in the last 12 months
- Mario Schlosser - $46.37M of OSCR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Richard T. Kenney?
Richard T. Kenney is a corporate insider, tracked as Chief Medical Officer of Sonnet BioTherapeutics Holdings, Inc. (SONN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Richard T. Kenney last file a Form 4?
The most recent primary Form 4 on record is dated 4 December 2025, one of 4 filings going back to 2024.
Where can I see all of Richard T. Kenney's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Richard T. Kenney and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial